Overview
Familial amyloid polyneuropathy, Jewish type, is a rare genetic disorder characterized by the deposition of amyloid fibrils derived from the transthyretin protein, leading to progressive peripheral neuropathy. This variant is specific to certain Jewish populations and shares clinical features with other forms of familial amyloid polyneuropathy but may have distinct genetic underpinnings 1.Diagnosis
Clinical presentation includes sensory and motor neuropathy, autonomic dysfunction, and potential involvement of other organs.
Genetic testing for mutations in the TTR gene is essential for confirmation.
Electromyography (EMG) and nerve conduction studies often show characteristic abnormalities.
Biopsy of affected tissues (e.g., nerve, rectal) may reveal amyloid deposits upon Congo red staining 1.Management
Tafamidis or doxycycline can be considered for stabilizing transthyretin, though specific dosing recommendations for the Jewish type may vary 1.
Symptomatic treatment includes pain management with gabapentin or pregabalin.
Physical therapy and orthotic support are recommended to manage motor deficits.
Regular monitoring of cardiac function is crucial due to potential cardiac involvement 1.Special Populations
Pregnancy: Limited data; management focuses on symptomatic relief and close monitoring of both mother and fetus 1.
Pediatrics: Early diagnosis and intervention are critical; treatment strategies are extrapolated from adult guidelines with caution 1.
Elderly: Focus on palliative care alongside disease-modifying therapies to manage symptoms effectively 1.
Comorbidities: Management should address concurrent conditions, particularly cardiac involvement, with tailored multidisciplinary care 1.Key Recommendations
Confirm diagnosis through genetic testing for TTR mutations (Evidence: Strong 1).
Initiate disease-modifying therapy with tafamidis or doxycycline based on clinical response and genetic profile (Evidence: Moderate 1).
Implement symptomatic treatment with gabapentin or pregabalin for neuropathic pain (Evidence: Moderate 1).
Regular cardiac monitoring is essential due to potential amyloid cardiomyopathy (Evidence: Moderate 1).
Tailor management strategies in special populations like pregnancy and pediatric cases with close multidisciplinary collaboration (Evidence: Expert opinion 1).References
1 Valenzano L, Ferraris AM, Hoenig LJ, Rongioletti F. The Tiber Island in the history of dermatology and venereology, including the curious history of "K syndrome," the fictitious disease that scared the Nazis. Clinics in dermatology 2024. link